Skip to content

José Carlos Bouso

International Council for the Exploration of the Sea, Universitat Rovira i Virgili

94 papers in the library · 4,302 citations · publishing 0-2026

Papers

Sort Most recent Most cited

The antiaddictive effects of ibogaine: A systematic literature review of human studies

Journal of Psychedelic Studies April 1, 2017 Rafael G. Dos Santos, José Carlos Bouso, Jaime E. C. Hallak 36 citations

Ibogaine is a naturally occurring hallucinogenic alkaloid with a therapeutic potential for reducing drug craving and withdrawal. To the best of our knowledge, no systematic review was previously performed assessing these effects. Thus, we conducted a systematic literature review of human studies assessing the antiaddictive effects of ibogaine. Papers published up to July 2, 2016 were included...

DOI: 10.1556/2054.01.2016.001 (opens in new tab) Addiction Opiate Hallucinogen Pharmacology +5

Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report

Journal of Psychedelic Studies April 1, 2017 Clare Wilkins, Rafael G. Dos Santos, Jordi Solà et al. 15 citations

Ibogaine is a natural alkaloid that has been used in the last decades as an adjuvant for the treatment of opiate withdrawal. Despite the beneficial results suggested by animal studies and case series, there is a lack of clinical trials to assess the safety and efficacy of ibogaine. Moreover, the majority of reports described cases of heroin-dependent individuals, with and without concomitant...

DOI: 10.1556/2054.01.2017.005 (opens in new tab) Detoxification alternative medicine Adverse effect Pharmacology Heroin +5

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

Therapeutic Advances in Psychopharmacology February 23, 2017 Rafael G. Dos Santos, José Carlos Bouso, Jaime E. C. Hallak 167 citations

Ayahuasca is a hallucinogen brew traditionally used for ritual and therapeutic purposes in Northwestern Amazon. It is rich in the tryptamine hallucinogens dimethyltryptamine (DMT), which acts as a serotonin 5-HT 2A agonist. This mechanism of action is similar to other compounds such as lysergic acid diethylamide (LSD) and psilocybin. The controlled use of LSD and psilocybin in experimental...

Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens.

Human Psychopharmacology: Clinical and Experimental September 1, 2016 José Carlos Bouso, Eduardo José Pedrero-Pérez, Sam Gandy et al. 48 citations

In the present study we explored the psychometric properties of three widely used questionnaires to assess the subjective effects of hallucinogens: the Hallucinogen Rating Scale (HRS), the Mystical Experience Questionnaire (MEQ), and the Addiction Research Center Inventory (ARCI). These three questionnaires were administered to a sample of 158 subjects (100 men) after taking ayahuasca, a...

The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

Journal of Psychopharmacology June 11, 2016 Rafael G. Dos Santos, Fermanda M Balthazar, José Carlos Bouso et al. 126 citations

Rationale: In recent decades, the use of ayahuasca (AYA) – a β-carboline- and dimethyltryptamine-rich hallucinogenic botanical preparation traditionally used by Northwestern Amazonian tribes for ritual and therapeutic purposes – has spread from South America to Europe and the USA, raising concerns about its possible toxicity and hopes of its therapeutic potential. Thus, it is important to...

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

European Neuropsychopharmacology January 16, 2015 José Carlos Bouso, Fernanda Palhano-Fontes, Antoni Rodrı́guez-fornells et al. 221 citations

Psychedelic agents have a long history of use by humans for their capacity to induce profound modifications in perception, emotion and cognitive processes. Despite increasing knowledge of the neural mechanisms involved in the acute effects of these drugs, the impact of sustained psychedelic use on the human brain remains largely unknown. Molecular pharmacology studies have shown that...

DOI: 10.1016/j.euroneuro.2015.01.008 (opens in new tab) Default mode network Posterior cingulate Hallucinogen Dissociative +3

Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study

Drug Testing and Analysis July 28, 2014 Jordi Riba, Ethan H. Mcilhenny, José Carlos Bouso et al. 96 citations

N , N ‐dimethyltryptamine (DMT) is a widely distributed plant alkaloid that displays partial agonist activity at the 5‐HT 2A receptor and induces intense psychedelic effects in humans when administered parenterally. However, self‐administration studies have reported a total lack of activity following oral intake. This is thought to be due to extensive degradation by monoamine oxidase (MAO)....

DOI: 10.1002/dta.1685 (opens in new tab) Oral administration Urine Ingestion Pharmacology +5

Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users

Psychopharmacology June 20, 2013 José Carlos Bouso, Josep María Fábregas, Rosa María Antonijoan et al. 96 citations

BackgroundAyahuasca, a South American psychotropic plant tea containing the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine, has been shown to increase regional cerebral blood flow in prefrontal brain regions after acute administration to humans. Despite interactions at this level, neuropsychological studies have not found cognitive deficits in abstinent long-term...

DOI: 10.1007/s00213-013-3167-9 (opens in new tab) Ayahuasca Stroop effect Neuropsychology Cognition +1

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

PLoS One August 8, 2012 José Carlos Bouso, Débora González, Sabela Fondevila et al. 313 citations

Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT(2A) agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North...

DOI: 10.1371/journal.pone.0042421 (opens in new tab) Ayahuasca Psychopathology Hallucinogen Impulsivity +2

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.

Journal of Psychopharmacology July 1, 2012 Fernando Caudevilla-Gálligo, Jordi Riba, Mireia Ventura et al. 99 citations

4-Bromo-2,5-dimethoxyphenethylamine (2C-B) is a psychoactive analogue of mescaline that is becoming increasingly popular as a rave and club drug. We investigated its presence in the illicit drug market in Spain, its pattern of use and profile of subjective effects. Drug material was analysed for 2C-B and information on pattern of use and subjective effects was obtained from recreational users....

DOI: 10.1177/0269881111431752 (opens in new tab) Full text (opens in new tab) 2c-b drug Synthetic drug 2c-b 2c-b substance Drug trends +18

Metabolism and disposition of N,N‐dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Drug Testing and Analysis April 19, 2012 Jordi Riba, Ethan H. Mcilhenny, Marta Valle et al. 91 citations

Ayahuasca is an Amazonian psychotropic plant tea obtained from Banisteriopsis caapi , which contains β ‐carboline alkaloids, chiefly harmine, harmaline and tetrahydroharmine. The tea usually incorporates the leaves of Psychotria viridis or Diplopterys cabrerana , which are rich in N , N ‐dimethyltryptamine (DMT), a psychedelic 5‐HT 2A/1A/2C agonist. The β ‐carbolines reversibly inhibit...

DOI: 10.1002/dta.1344 (opens in new tab) Ayahuasca Harmine Harmaline Alkaloid +8

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

Journal of Clinical Psychopharmacology October 15, 2011 Rafael G. Dos Santos, Marta Valle, José Carlos Bouso et al. 136 citations

Ayahuasca is an Amazonian psychotropic plant tea combining the 5-HT2A agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting β-carboline alkaloids that render DMT orally active. The tea, obtained from Banisteriopsis caapi and Psychotria viridis, has traditionally been used for religious, ritual, and medicinal purposes by the indigenous peoples of the region. More recently, the...

DOI: 10.1097/jcp.0b013e31823607f6 (opens in new tab) Ayahuasca Hallucinogen Pharmacology Amphetamine +2

Pharmacology of ayahuasca administered in two repeated doses

Psychopharmacology August 12, 2011 Rafael G. Dos Santos, Eva Grasa, Marta Valle et al. 139 citations

RationaleAyahuasca is an Amazonian tea containing the natural psychedelic 5-HT(2A/2C/1A) agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its visionary properties. The human pharmacology of ayahuasca has been well characterized following its administration in single doses.ObjectivesTo evaluate the human pharmacology of ayahuasca in repeated doses and assess the...

DOI: 10.1007/s00213-011-2434-x (opens in new tab) Ayahuasca Placebo Crossover study Pharmacology +3

Assessment of addiction severity among ritual users of ayahuasca

Drug and Alcohol Dependence June 17, 2010 Josep María Fábregas, Débora González, Sabela Fondevila et al. 228 citations

Ayahuasca is a psychoactive beverage used for magico-religious purposes in the Amazon. Recently, Brazilian syncretic churches have helped spread the ritual use of ayahuasca abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine-containing tea may lead to the medical and psychosocial problems typically associated with drugs of abuse. Here we assess potential drug...

MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder

Journal of Psychoactive Drugs September 1, 2008 José Carlos Bouso, Rick Doblin, Magı́ Farré et al. 206 citations

The purpose of this study was to investigate the safety of different doses of MDMA-assisted psychotherapy administered in a psychotherapeutic setting to women with chronic PTSD secondary to a sexual assault, and also to obtain preliminary data regarding efficacy. Although this study was originally planned to include 29 subjects, political pressures led to the closing of the study before it...

DOI: 10.1080/02791072.2008.10400637 (opens in new tab) MDMA Posttraumatic stress Clinical psychology

Pattern of use and subjective effects of Salvia divinorum among recreational users.

Drug and Alcohol Dependence November 8, 2006 Débora González, Jordi Riba, José Carlos Bouso et al. 163 citations

Salvia divinorum is a member of the Lamiaceae family and contains the psychotropic diterpene and kappa-opioid receptor agonist salvinorin-A. Originally a shamanic inebriant used by the Mexican Mazatec Indians, the plant and its preparations are becoming increasingly popular among non-traditional users. Demographic data and information on pattern of use and subjective effects were obtained by...

Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series.

Journal of Clinical Psychopharmacology María Gómez-sousa, Daniel Jiménez‐garrido, Genís Ona et al. 24 citations

In recent decades, ritualistic use of ayahuasca has spread throughout the world. Retrospective studies have suggested a good psychological safety profile, but prospective studies involving ceremony ayahuasca-naive participants are lacking. We conducted the study using a subsample from a previous study, for which first-time ceremony ayahuasca participants were recruited. The subsample consisted...

Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial.

Journal of Clinical Psychopharmacology Giordano Novak Rossi, Juliana Mendes Rocha, Flávia L. Osório et al. 12 citations

Serotonergic hallucinogens and cannabinoids may alter the recognition of emotions in facial expressions (REFE). Cannabidiol (CBD) attenuates the psychoactive effects of the cannabinoid-1 agonist tetrahydrocannabinol. Ayahuasca is a dimethyltryptamine-containing hallucinogenic decoction. It is unknown if CBD may moderate and attenuate the effects of ayahuasca on REFE. Seventeen healthy...

DOI: 10.1097/jcp.0000000000001691 (opens in new tab) Full text (opens in new tab) Psychedelics Plant medicine Clinical research Mental health

Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial.

Journal of Clinical Psychopharmacology Lucas Silva Rodrigues, José Augusto Silva Reis, Giordano Novak Rossi et al. 8 citations

Ayahuasca is a South American plant hallucinogen rich in the psychedelic N,N-dimethyltryptamine and β-carbolines (mainly harmine). Preclinical and observational studies suggest that ayahuasca exerts beneficial effects in substance use disorders, but these potentials were never assessed in a clinical trial. Single-center, single-blind, feasibility, proof-of-concept study, assessing the effects...

DOI: 10.1097/jcp.0000000000001872 (opens in new tab) Full text (opens in new tab) Ayahuasca medicine Psychedelics Addiction treatment Substance abuse +1